IBDEI014 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,907,2)
 ;;=^269618
 ;;^UTILITY(U,$J,358.3,908,0)
 ;;=404.11^^9^78^33
 ;;^UTILITY(U,$J,358.3,908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,908,1,4,0)
 ;;=4^404.11
 ;;^UTILITY(U,$J,358.3,908,1,5,0)
 ;;=5^HTN with CHF & Renal Involvement
 ;;^UTILITY(U,$J,358.3,908,2)
 ;;=^269619
 ;;^UTILITY(U,$J,358.3,909,0)
 ;;=404.12^^9^78^36
 ;;^UTILITY(U,$J,358.3,909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,909,1,4,0)
 ;;=4^404.12
 ;;^UTILITY(U,$J,358.3,909,1,5,0)
 ;;=5^HTN with Heart Involvement & Renal Failure
 ;;^UTILITY(U,$J,358.3,909,2)
 ;;=^269620
 ;;^UTILITY(U,$J,358.3,910,0)
 ;;=404.13^^9^78^34
 ;;^UTILITY(U,$J,358.3,910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,910,1,4,0)
 ;;=4^404.13
 ;;^UTILITY(U,$J,358.3,910,1,5,0)
 ;;=5^HTN with CHF & Renal failure
 ;;^UTILITY(U,$J,358.3,910,2)
 ;;=^269621
 ;;^UTILITY(U,$J,358.3,911,0)
 ;;=401.9^^9^78^57
 ;;^UTILITY(U,$J,358.3,911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,911,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,911,1,5,0)
 ;;=5^Hypertension, Essential
 ;;^UTILITY(U,$J,358.3,911,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,912,0)
 ;;=272.0^^9^78^55
 ;;^UTILITY(U,$J,358.3,912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,912,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,912,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,912,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,913,0)
 ;;=272.1^^9^78^58
 ;;^UTILITY(U,$J,358.3,913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,913,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,913,1,5,0)
 ;;=5^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,913,2)
 ;;=Hypertriglyceridemia^101303
 ;;^UTILITY(U,$J,358.3,914,0)
 ;;=272.2^^9^78^63
 ;;^UTILITY(U,$J,358.3,914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,914,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,914,1,5,0)
 ;;=5^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,914,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,915,0)
 ;;=396.0^^9^78^11
 ;;^UTILITY(U,$J,358.3,915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,915,1,4,0)
 ;;=4^396.0
 ;;^UTILITY(U,$J,358.3,915,1,5,0)
 ;;=5^Aortic and Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,915,2)
 ;;=Aortic and Mitral Stenosis^269580
 ;;^UTILITY(U,$J,358.3,916,0)
 ;;=414.02^^9^78^18
 ;;^UTILITY(U,$J,358.3,916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,916,1,4,0)
 ;;=4^414.02
 ;;^UTILITY(U,$J,358.3,916,1,5,0)
 ;;=5^CAD, Occlusion of Venous Graft
 ;;^UTILITY(U,$J,358.3,916,2)
 ;;=CAD, Occlusion of Venous Graft^303282
 ;;^UTILITY(U,$J,358.3,917,0)
 ;;=459.10^^9^78^73
 ;;^UTILITY(U,$J,358.3,917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,917,1,4,0)
 ;;=4^459.10
 ;;^UTILITY(U,$J,358.3,917,1,5,0)
 ;;=5^Post Phlebotic Syndrome
 ;;^UTILITY(U,$J,358.3,917,2)
 ;;=Post Phlebotic Syndrome^328597
 ;;^UTILITY(U,$J,358.3,918,0)
 ;;=428.20^^9^78^50
 ;;^UTILITY(U,$J,358.3,918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,918,1,4,0)
 ;;=4^428.20
 ;;^UTILITY(U,$J,358.3,918,1,5,0)
 ;;=5^Heart Failure, Systolic, Unspec
 ;;^UTILITY(U,$J,358.3,918,2)
 ;;=Heart Failure, Systolic^328594
 ;;^UTILITY(U,$J,358.3,919,0)
 ;;=428.21^^9^78^42
 ;;^UTILITY(U,$J,358.3,919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,919,1,4,0)
 ;;=4^428.21
 ;;^UTILITY(U,$J,358.3,919,1,5,0)
 ;;=5^Heart Failure, Acute Systolic
 ;;^UTILITY(U,$J,358.3,919,2)
 ;;=Heart Failure, Acute Systolic^328494
 ;;^UTILITY(U,$J,358.3,920,0)
 ;;=428.22^^9^78^44
 ;;^UTILITY(U,$J,358.3,920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,920,1,4,0)
 ;;=4^428.22
 ;;^UTILITY(U,$J,358.3,920,1,5,0)
 ;;=5^Heart Failure, Chronic Systolic
 ;;^UTILITY(U,$J,358.3,920,2)
 ;;=Heart Failure, Chronic Systolic^328495
 ;;^UTILITY(U,$J,358.3,921,0)
 ;;=428.23^^9^78^49
 ;;^UTILITY(U,$J,358.3,921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,921,1,4,0)
 ;;=4^428.23
 ;;^UTILITY(U,$J,358.3,921,1,5,0)
 ;;=5^Heart Failure, Systolic, Acute on Chronic
 ;;^UTILITY(U,$J,358.3,921,2)
 ;;=Heart Failure, Systolic, Acute on Chronic^328496
 ;;^UTILITY(U,$J,358.3,922,0)
 ;;=428.30^^9^78^45
 ;;^UTILITY(U,$J,358.3,922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,922,1,4,0)
 ;;=4^428.30
 ;;^UTILITY(U,$J,358.3,922,1,5,0)
 ;;=5^Heart Failure, Diastolic
 ;;^UTILITY(U,$J,358.3,922,2)
 ;;=Heart Failure, Diastolic^328595
 ;;^UTILITY(U,$J,358.3,923,0)
 ;;=428.31^^9^78^41
 ;;^UTILITY(U,$J,358.3,923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,923,1,4,0)
 ;;=4^428.31
 ;;^UTILITY(U,$J,358.3,923,1,5,0)
 ;;=5^Heart Failure, Acute Diastolic
 ;;^UTILITY(U,$J,358.3,923,2)
 ;;=Heart Failure, Acute Diastolic^328497
 ;;^UTILITY(U,$J,358.3,924,0)
 ;;=428.32^^9^78^43
 ;;^UTILITY(U,$J,358.3,924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,924,1,4,0)
 ;;=4^428.32
 ;;^UTILITY(U,$J,358.3,924,1,5,0)
 ;;=5^Heart Failure, Chronic Diastolic
 ;;^UTILITY(U,$J,358.3,924,2)
 ;;=Heart Failure, Chronic Diastolic^328498
 ;;^UTILITY(U,$J,358.3,925,0)
 ;;=428.33^^9^78^47
 ;;^UTILITY(U,$J,358.3,925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,925,1,4,0)
 ;;=4^428.33
 ;;^UTILITY(U,$J,358.3,925,1,5,0)
 ;;=5^Heart Failure, Diastolic, Acute on Chronic
 ;;^UTILITY(U,$J,358.3,925,2)
 ;;=Heart Failure, Diastolic, Acute on Chronic^328499
 ;;^UTILITY(U,$J,358.3,926,0)
 ;;=428.40^^9^78^46
 ;;^UTILITY(U,$J,358.3,926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,926,1,4,0)
 ;;=4^428.40
 ;;^UTILITY(U,$J,358.3,926,1,5,0)
 ;;=5^Heart Failure, Diastolic& Systolic
 ;;^UTILITY(U,$J,358.3,926,2)
 ;;=Heart Failure, Systolic and Diastolic^328596
 ;;^UTILITY(U,$J,358.3,927,0)
 ;;=428.41^^9^78^48
 ;;^UTILITY(U,$J,358.3,927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,927,1,4,0)
 ;;=4^428.41
 ;;^UTILITY(U,$J,358.3,927,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute
 ;;^UTILITY(U,$J,358.3,927,2)
 ;;=Heart Failure, Systolic & Diastolic, Acute^328500
 ;;^UTILITY(U,$J,358.3,928,0)
 ;;=428.42^^9^78^52
 ;;^UTILITY(U,$J,358.3,928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,928,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,928,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,928,2)
 ;;=^328501
 ;;^UTILITY(U,$J,358.3,929,0)
 ;;=428.43^^9^78^51
 ;;^UTILITY(U,$J,358.3,929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,929,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,929,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic
 ;;^UTILITY(U,$J,358.3,929,2)
 ;;=^328502
 ;;^UTILITY(U,$J,358.3,930,0)
 ;;=396.3^^9^78^10
 ;;^UTILITY(U,$J,358.3,930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,930,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,930,1,5,0)
 ;;=5^Aortic and Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,930,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,931,0)
 ;;=429.9^^9^78^28
 ;;^UTILITY(U,$J,358.3,931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,931,1,4,0)
 ;;=4^429.9
 ;;^UTILITY(U,$J,358.3,931,1,5,0)
 ;;=5^Diastolic Dysfunction
 ;;^UTILITY(U,$J,358.3,931,2)
 ;;=^54741
 ;;^UTILITY(U,$J,358.3,932,0)
 ;;=453.79^^9^78^27
 ;;^UTILITY(U,$J,358.3,932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,932,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,932,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,932,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,933,0)
 ;;=453.89^^9^78^1
 ;;^UTILITY(U,$J,358.3,933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,933,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,933,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,933,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,934,0)
 ;;=454.2^^9^78^85
 ;;^UTILITY(U,$J,358.3,934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,934,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,934,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,934,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,935,0)
 ;;=397.1^^9^78^74
 ;;^UTILITY(U,$J,358.3,935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,935,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,935,1,5,0)
 ;;=5^Rheumatic Disease Pulmonary Valve
 ;;^UTILITY(U,$J,358.3,935,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,936,0)
 ;;=397.0^^9^78^75
 ;;^UTILITY(U,$J,358.3,936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,936,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,936,1,5,0)
 ;;=5^Rheumatic Disease Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,936,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,937,0)
 ;;=414.3^^9^78^17
 ;;^UTILITY(U,$J,358.3,937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,937,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,937,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,937,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,938,0)
 ;;=414.4^^9^78^16
 ;;^UTILITY(U,$J,358.3,938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,938,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,938,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,938,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,939,0)
 ;;=425.11^^9^78^60
 ;;^UTILITY(U,$J,358.3,939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,939,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,939,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,939,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,940,0)
 ;;=425.18^^9^78^59
 ;;^UTILITY(U,$J,358.3,940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,940,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,940,1,5,0)
 ;;=5^Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,940,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,941,0)
 ;;=V12.55^^9^78^54
 ;;^UTILITY(U,$J,358.3,941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,941,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,941,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,941,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,942,0)
 ;;=454.9^^9^78^84
 ;;^UTILITY(U,$J,358.3,942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,942,1,4,0)
 ;;=4^454.9
 ;;^UTILITY(U,$J,358.3,942,1,5,0)
 ;;=5^Varicose Veins
 ;;^UTILITY(U,$J,358.3,942,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,943,0)
 ;;=271.3^^9^79^11
 ;;^UTILITY(U,$J,358.3,943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,943,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,943,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,943,2)
 ;;=^64790
